← Back to Search

3D-RT for Dementia

N/A
Recruiting
Led By Thomas Plocher, MS
Research Sponsored by Moai Technologies LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
English speaking
Physician diagnosis of early-stage Alzheimer's disease or mild cognitive impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up will be administered at week 0 (prior to first therapy session) to establish a baseline. measures at week 8 (midpoint of therapy sessions), and week 16 (following last therapy session) will determine change from the baseline.
Awards & highlights

Study Summary

This trial will use 3D printing to create personalized objects for people with dementia, in order to improve their mood, quality of life, social interaction, and cognition.

Eligible Conditions
  • Dementia

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~will be administered at week 0 (prior to first therapy session) to establish a baseline. measures at week 8 (midpoint of therapy sessions), and week 16 (following last therapy session) will determine change from the baseline.
This trial's timeline: 3 weeks for screening, Varies for treatment, and will be administered at week 0 (prior to first therapy session) to establish a baseline. measures at week 8 (midpoint of therapy sessions), and week 16 (following last therapy session) will determine change from the baseline. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Cognitive stimulation/reminiscence
Secondary outcome measures
Dementia
Change in Dementia severity-SLUMS
Change in Dementia severity-dependence on assistance
+3 more
Other outcome measures
Functionality and usability of 3D printing mobile tools and paradigm for RT

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: 8 Weeks of 3D-RTExperimental Treatment1 Intervention
Participants will receive 8weeks of Reminiscence Therapy using 3D printed objects as stimuli and 8 weeks of RT using verbal stimuli.
Group II: 16 Weeks of 3D-RTExperimental Treatment1 Intervention
Participants will receive 16 weeks of Reminiscence Therapy using 3D printed objects as stimuli.
Group III: 16 Weeks of RT using Verbal StimuliActive Control1 Intervention
Participants will receive 16 weeks of RT using verbal stimuli to reminiscence.

Find a Location

Who is running the clinical trial?

The University of Texas at ArlingtonOTHER
40 Previous Clinical Trials
4,638 Total Patients Enrolled
2 Trials studying Dementia
533 Patients Enrolled for Dementia
Moai Technologies LLCLead Sponsor
1 Previous Clinical Trials
96 Total Patients Enrolled
University of Texas-ArlingtonUNKNOWN
4 Previous Clinical Trials
600 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
~46 spots leftby Mar 2025